亚太病毒学市场预测至 2028 年 - COVID-19 影响和按类型（诊断测试、病毒感染控制技术、抗病毒治疗和干扰素）、应用（皮肤和软组织感染、呼吸道感染、胃肠道感染、性）的区域分析传染病、尿路感染等）和最终用户（医院、诊断实验室、制药和生物技术公司以及研究和学术机构）

亚太地区由五个主要国家组成，即中国、日本、印度、澳大利亚、韩国以及亚太地区其他国家。还对亚太地区其他国家的市场进行了评估。该市场受到中国和印度等人口大国、市场参与者对该地区的日益关注以及该国新产品推出等因素的推动。此外，流感、艾滋病毒和其他传染病发病率的增加正在推动市场增长。此外，人们对更好的治疗程序和技术进步的认识不断增强，医疗保健支出的增加和先进技术的可用性有助于促进该地区病毒学市场的增长。新兴经济体的强劲增长是推动亚太地区病毒学市场增长的主要因素。

COVID-19 在全球范围内造成了前所未有的公共卫生紧急情况。事实证明，新出现的传染病对全世界的生存构成威胁。快速城市化、森林砍伐、集约化农业、畜牧业和全球化正在增加该地区动物与人类接触和流行病的机会。由于现在有大量人口居住在城市，城市化正在为流行病和大流行病创造更大的可能性。此外，许多国家在以往疫情的基础上成功遏制了COVID-19。例如，韩国中央政府开始投资国内研发传染病检测所需的诊断试剂。从2017年开始，它已在传染病诊断技术方面投资约2500万美元。事实证明，商业制造商通过政府研发投资开发的测试技术（包括人工智能 (AI)）对于政府快速启动有效的 COVID-19 应对策略至关重要。然而，COVID-19 大流行对东南亚地区的基本艾滋病毒卫生服务产生了重大影响，使过去二十年的增长面临风险。 COVID-19 扰乱了基本服务，导致药品和其他卫生用品的交付严重延误。艾滋病毒诊所和医护人员的优先事项不断变化、旅行限制、公共交通不可用和私人交通有限以及社会经济环境恶化，影响了基本艾滋病毒服务的连续性。吉利德科学公司 (Gilead Sciences) 进行的一项调查显示，自疫情爆发以来，菲律宾艾滋病诊所就诊次数出现了 70% 以上的延误或减少。艾滋病毒和艾滋病是最近的全球流行病，全球基金在过去 20 年中取得了巨大进展。研究显示，超过 82% 的印度处方医生表示，艾滋病毒感染者的就诊减少或延迟。 COVID-19 还对 HIV 检测的采用率产生了负面影响，约 46% 的高危人群报告说，在 COVID-19 期间，接受 HIV 检测的人数有所减少。检测减少的主要原因是接触 COVID-19 (62%) 和旅行限制 (46%)，因为 HIV 检测大多只能在护理点进行。因此，它对艾滋病毒护理和其他病毒感染产生了负面影响。

市场概况和动态

亚太地区的病毒学市场预计将从2021年的9.3192亿美元增长到2028年的12.3444亿美元；预计 2021 年至 2028 年复合年增长率为 4.1%。病毒感染是人类慢性疾病的主要原因之一。人类免疫缺陷病毒 (HIV)、流感病毒、寨卡病毒、白喉病毒、埃博拉病毒、SARS-CoV-2 (COVID-19)、脊髓灰质炎和破伤风 (牙关紧闭症) 等少数病毒感染了世界各地的大量人群。随着病毒不断变异和进化，耐药性成为人类和动物病毒感染管理迫在眉睫的挑战。病毒根据其类型通过各种介质传播。例如，一些病毒会引起呼吸道病毒性疾病，如流感、普通感冒和呼吸道合胞病毒感染，通过咳嗽或打喷嚏产生的飞沫传播；也有一些是因为胃肠道病毒性疾病通过粪便污染的食物或水传播。根据联合国艾滋病毒与艾滋病规划署艾滋病统计数据显示，2020年全球有超过3770万人感染艾滋病毒。导致COVID-19的新型冠状病毒于2019年被识别。国际病毒分类委员会（ICTV）宣布该病毒为严重急性呼吸系统综合症冠状病毒2020 年 2 月 11 日，该病毒被命名为“SARS-CoV-2”，后来世界卫生组织将该疾病命名为“COVID-19”。该病毒自爆发以来已经发生了几次突变，这加剧了 COVID-19 大流行的严重性。因此，病毒感染流行率的上升推动了亚太地区病毒学市场的增长。

主要细分市场

亚太地区病毒学市场根据类型、应用、最终用户和国家进行细分。根据类型，市场分为诊断测试、病毒感染控制技术、抗病毒治疗和干扰素。抗病毒治疗领域在 2020 年占据市场主导地位，病毒感染控制技术领域预计将在预测期内增长最快。诊断测试部分进一步分为DNA病毒测试、RNA病毒测试等。同样，病毒感染控制技术分为主动预防和被动预防。同样，抗病毒治疗分为杀病毒剂、抗病毒剂、免疫调节剂和干扰素。根据应用，病毒学市场分为皮肤和软组织感染、呼吸道感染、胃肠道感染、性传播疾病、尿路感染等。呼吸道感染领域在 2020 年占据市场主导地位，预计将在预测期内增长最快。根据最终用户，病毒学市场分为医院、诊断实验室、制药和生物技术公司以及研究和学术机构。医院细分市场在 2020 年占据市场主导地位，诊断实验室细分市场预计将在预测期内增长最快。

主要来源和上市公司

准备本亚太地区病毒学市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有雅培（Abbott）；艾伯维公司； F.霍夫曼-拉罗氏有限公司；吉利德科学公司；葛兰素史克公司；照明公司；强生服务公司；凯杰；西门子公司；和 Thermo Fisher Scientific Inc. 等。

购买报告的理由

了解亚太地区病毒学市场格局，并确定最有可能保证丰厚回报的细分市场
通过理解亚太地区病毒学市场不断变化的竞争格局
通过识别最有可能销售前景的细分市场，有效规划亚太地区病毒学市场的并购和合作交易
帮助通过对亚太地区病毒学市场各个细分市场的市场表现进行敏锐和全面的分析，做出明智的业务决策
获取亚太地区各个细分市场 2021 年至 2028 年的市场收入预测。

亚太地区病毒学市场细分

亚太地区病毒学市场 - 按类型

诊断检测
- DNA病毒检测
- RNA病毒检测
- 其他
病毒感染控制技术
- 主动预防
- 被动预防
抗病毒治疗
- 杀病毒剂
- 抗病毒药物
- 免疫调节剂
干扰素

亚太地区病毒学市场 - 按应用

亚太地区病毒学市场 - 按最终用户划分

医院
诊断实验室
制药和生物技术公司
研究和学术机构

亚太地区病毒学市场 - 按国家/地区

< ul>

中国

日本

印度

澳大利亚

韩国

亚太地区其他地区

亚太地区病毒学市场 -公司简介

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Virology Market – By Type

1.3.2 APAC Virology Market – By Application

1.3.3 APAC Virology Market – By End User

1.3.4 APAC Virology Market– By Country

2. APAC Virology Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Virology Market– Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Virology Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Viral Infectious Diseases

5.1.2 Increasing Product Launches

5.2 Market Restraints

5.2.1 Availability of Alternative Products and High Cost of Production of Products

5.3 Market Opportunities

5.3.1 Surging Growth in Several Economies

5.4 Future Trends

5.4.1 Continuous Demand for Cost-Effective Products

5.5 Impact Analysis

6. Virology Market– APAC Analysis

6.1 APAC Virology Market Revenue Forecast and Analysis

7. APAC Virology Market Analysis – By Type

7.1 Overview

7.2 APAC Virology Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Test

7.3.1 Overview

7.3.2 Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Deoxyribonucleic Acid (DNA) Virus Testing

7.3.2.1.1 Overview

7.3.2.1.2 DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Ribonucleic Acid (RNA) Virus Testing

7.3.2.2.1 Overview

7.3.2.2.2 RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Others

7.3.2.3.1 Overview

7.3.2.3.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Viral Infection Controlling Techniques

7.4.1 Overview

7.4.2 Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Active Prophylaxis

7.4.2.1.1 Overview

7.4.2.1.2 Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2 Passive Prophylaxis

7.4.2.2.1 Overview

7.4.2.2.2 Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Antiviral Therapeutics

7.5.1 Overview

7.5.2 Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1 Virucidal Agents

7.5.2.1.1 Overview

7.5.2.1.2 Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2 Antiviral Agents

7.5.2.2.1 Overview

7.5.2.2.2 Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3 Immunomodulators

7.5.2.3.1 Overview

7.5.2.3.2 Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Interferons

7.6.1 Overview

7.6.2 Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8. APAC Virology Market Analysis – By Application

8.1 Overview

8.2 APAC Virology Market, by Application 2021 & 2028 (%)

8.3 Skin and Soft Tissue Infections

8.3.1 Overview

8.3.2 Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Respiratory Tract Infections

8.4.1 Overview

8.4.2 Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.5 GI Tract Infections

8.5.1 Overview

8.5.2 GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Sexually Transmitted Diseases

8.6.1 Overview

8.6.2 Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Urinary Tract Infections

8.7.1 Overview

8.7.2 Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9. APAC Virology Market Analysis – By End User

9.1 Overview

9.2 APAC Virology Market Revenue Share, by End User (2021 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Diagnostic Laboratories

9.4.1 Overview

9.4.2 Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Pharmaceutical and Biotechnological Companies

9.5.1 Overview

9.5.2 Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Research and Academic Institutes

9.6.1 Overview

9.6.2 Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

10. APAC Virology Market – Country Analysis

10.1.1 Overview

10.1.2 Asia Pacific: Virology Market, by Country, 2021 & 2028 (%)

10.1.2.1 China: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 China: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 China: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.1.2.1 China: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.1.2.2 China: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.1.2.3 China: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.1.3 China: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4 China: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.2 Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Japan: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.2.2.1 Japan: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.2.2.2 Japan: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.2.2.3 Japan: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.2.3 Japan: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4 Japan: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.3 India: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 India: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 India: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.3.2.1 India: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.3.2.2 India: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.3.2.3 India: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.3.3 India: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4 India: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.4 South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 South Korea: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.4.2.1 South Korea: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.4.2.2 South Korea: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.4.2.3 South Korea: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.4.3 South Korea: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.4.4 South Korea: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.5 Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1 Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2 Australia: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.5.2.1 Australia: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.5.2.2 Australia: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.5.2.3 Australia: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.5.3 Australia: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.5.4 Australia: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.6 Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of Asia Pacific: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.6.2.1 Rest of Asia Pacific: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.6.2.2 Rest of Asia Pacific: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.6.2.3 Rest of Asia Pacific: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.6.3 Rest of Asia Pacific: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.6.4 Rest of Asia Pacific: Virology Market, by End User, 2019–2028 (USD Million)

11. Impact of COVID-19 Pandemic on APAC Virology Market

11.1 Overview

12. APAC Virology Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Johnson and Johnson Services, Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 F. HOFFMANN-LA ROCHE LTD.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 QIAGEN

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Illumina, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Siemens AG

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 GlaxoSmithKline Plc

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 AbbVie Inc.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Gilead Sciences, Inc.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Virology Market Revenue and Forecast to 2028 (US$ Million)

Table 2. China: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3. China Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 4. China Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 5. China Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 6. China: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7. China: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 8. Japan: Virology Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 9. Japan Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 10. Japan Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 11. Japan Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 12. Japan: Virology Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 13. Japan: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14. India: Virology Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 15. India Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 16. India Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 17. India Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 18. India: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19. India: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 20. South Korea: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 21. South Korea Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 22. South Korea Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 23. South Korea Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 24. South Korea: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 25. South Korea: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 26. Australia: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 27. Australia Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 28. Australia Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 29. Australia Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 30. Australia: Virology Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 31. Australia: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 32. Rest of Asia Pacific: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 33. Rest of Asia Pacific Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 34. Rest of Asia Pacific Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 35. Rest of Asia Pacific Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 36. Rest of Asia Pacific: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 37. Rest of Asia Pacific: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 38. Organic Developments Done by Companies

Table 39. Inorganic Developments Done by Companies

Table 40. Glossary of Terms, APAC Virology Market

LIST OF FIGURES

Figure 1. APAC Virology Market Segmentation

Figure 2. APAC Virology Segmentation, By Country

Figure 3. APAC Virology Market Overview

Figure 4. Antiviral Therapeutics Held the Largest Share of the Type Segment in APAC Virology Market

Figure 5. Respiratory Tract Infections Held the Largest Share of the Application Segment in APAC Virology Market

Figure 6. India to Show Significant Growth During Forecast Period

Figure 7. APAC PEST Analysis

Figure 8. APAC Virology Market: Impact Analysis of Drivers and Restraints

Figure 9. APAC Virology Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10. APAC Virology Market Revenue Share, by Type (2021 and 2028)

Figure 11. APAC Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. APAC DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. APAC RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. APAC Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. APAC Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. APAC Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. APAC Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. APAC Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. APAC Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. APAC Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. APAC Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. APAC Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. APAC Virology Market, by Application 2021 & 2028 (%)

Figure 24. APAC Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. APAC Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. APAC GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. APAC Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. APAC Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. APAC Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. APAC Virology Market Revenue Share, by End User (2021 and 2028)

Figure 31. APAC Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. APAC Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. APAC Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. APAC Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Asia Pacific: Virology Market, by Key Country – Revenue (2021) (USD Million)

Figure 36. Asia Pacific: Virology Market, by Country, 2021 & 2028 (%)

Figure 37. China: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 39. India: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 41. Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 42. Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 43. Impact of COVID-19 Pandemic on Virology Market in APAC Countries

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC Virology market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC Virology market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the Virology market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample